RGEN
Repligen Corp
A maker of tools and consumables for biologic drug manufacturing, Repligen supplies cell-retention filters, pre-packed columns, purification resins, and growth factors used by drugmakers worldwide. Founded in 1981 in Cambridge, Massachusetts, by two molecular biology professors, it focused entirely on bioprocessing starting in 2012. Its name blends "replication" and "genetics," a nod to its roots in recombinant protein science.
CUSIP: 759916109HealthcareUS2 holders
Total Value
$276.34M
Total Shares
2.03M
Net Share Change
+481.0K
Activity
2 buying
Investor
Value
Shares
Weight
Change
